Výsledky vyhledávání - "Michael McGoon"

Change In Diffusing Capacity For Carbon Monoxide As A Predictor Of Outcomes In Connective Tissue Disease Associated Pulmonary Arterial Hypertension: Analysis From The REVEAL Registry

Autor: Roham T. Zamanian, Kristina Kudelko, Dave P. Miller, Leslie Meltzer, Michael McGoon, Raymond L. Benza, Paul M. Hassoun, Mark R. Nicolls, Lorinda Chung

Publikováno v: B107. BIOMARKERS AND PREDICTORS OF OUTCOMES IN PULMONARY HYPERTENSION.

Background: Change in diffusing capacity for carbon monoxide (DLCO) is a more powerful predictor of outcomes than baseline DLCO in connective tissue disease (CTD)-associated pulmonary arterial hypertension (PAH). Aims and Objectives: We sought to val

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8150f3e2d7511cff43fd716af3d1fdcc
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3836

Zobrazit plný text záznamu

ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension

Autor: David B, Badesch, Jeremy, Feldman, Anne, Keogh, Michael A, Mathier, Ronald J, Oudiz, Shelley, Shapiro, Harrison W, Farber, Michael, McGoon, Adaani, Frost, Martine, Allard, Darrin, Despain, Christopher, Dufton, Lewis J, Rubin, F, Witherspoon

Publikováno v: Cardiovascular therapeutics. 30(2)

Ambrisentan is an oral, once daily, endothelin receptor antagonist approved for treatment of pulmonary arterial hypertension (PAH). Previous studies of ambrisentan were limited to patients with Group 1 PAH and often excluded patients receiving other

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::643b73b19ff9aff9f9465ef0fea5be48
https://pubmed.ncbi.nlm.nih.gov/21884013

Zobrazit plný text záznamu

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL: Identifying Systemic Sclerosis as a Unique Phenotype

Autor: Lorinda, Chung, Juliana, Liu, Lori, Parsons, Paul M, Hassoun, Michael, McGoon, David B, Badesch, Dave P, Miller, Mark R, Nicolls, Roham T, Zamanian

REVEAL (the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management) is the largest US cohort of patients with pulmonary arterial hypertension (PAH) confirmed by right-sided heart catheterization (RHC), providing a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5e578256014a52cd7f263d094f459143
https://europepmc.org/articles/PMC3621419/

Zobrazit plný text záznamu

Pulmonary Hypertension

Autor: Michael McGoon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cd240de2e5221898dff9b285ab77f68c
https://doi.org/10.1201/b14443-87

Zobrazit plný text záznamu

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

Autor: Michael, McGoon, David, Gutterman, Virginia, Steen, Robin, Barst, Douglas C, McCrory, Terry A, Fortin, James E, Loyd

Publikováno v: Chest. 126

Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component of a variety of disease processes, including chronic thromboembolic disease, connective tissue diseases, congenital heart disease, and exposure to exogenous facto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d26115bbdc25a2ff2a8c56612353ff5d
https://pubmed.ncbi.nlm.nih.gov/15249493

Zobrazit plný text záznamu

PHA Scientific Sessions Break New Ground, Providing Timely, Focused Venue for Current Research

Autor: Michael McGoon

Publikováno v: Advances in Pulmonary Hypertension. 3:3-3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc183a0819a2a1d3c9fafeb483fceb24
https://doi.org/10.21693/1933-088x-3.3.3a

Zobrazit plný text záznamu

Beraprost therapy for pulmonary arterial hypertension

Autor: Robyn J, Barst, Michael, McGoon, Vallerie, McLaughlin, Victor, Tapson, Stuart, Rich, Lewis, Rubin, Karlman, Wasserman, Ronald, Oudiz, Shelley, Shapiro, Ivan M, Robbins, Richard, Channick, David, Badesch, Barry K, Rayburn, Robin, Flinchbaugh, Jeff, Sigman, Carl, Arneson, Roger, Jeffs

Publikováno v: Journal of the American College of Cardiology. (12):2119-2125

ObjectivesThe purpose of this study was to assess the safety and efficacy of the oral prostacyclin analogue beraprost sodium during a 12-month double-blind, randomized, placebo-controlled trial in patients with pulmonary arterial hypertension (PAH).B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c279ea1fefd8ba2f25c879039a15b6

Zobrazit plný text záznamu